Preliminary Program
Preliminary Program: Monday, May 16
Psychiatric News
Volume 46 Number 4 page 29-40

New Research Young Investigator Poster Session 5


Scientific and Clinical Report

SCR19. Historical and Research Issues

  • 63. The Participation of German Physicians in the So-Called "Euthanasia Program" During the Third Reich: Motivations, Verdicts, and Sentences Robert McKelvey, M.D.

  • 64. Development of a Comorbidity Index for Mental Health Dianne Groll, Ph.D.

  • 65. Dreaming With Jung: Carl Jung's Red Book and Critical Implications for Psychiatric Practice 90 Years Later Scott Simpson, M.D., M.P.H.

  • 66. Risks of Readmission in Patients Diagnosed With Bipolar, Major Depressive, or Schizoaffective Disorders: A Longitudinal Study Stephen Woolley, D.Sc., M.P.H.

  • +


    W51. Charting the Next Frontier in Psychiatry: The Applications, Barriers, and Impact of Telepsychiatry on Mental Health CareChairs: Sonya Lazarevic, M.D., M.S.W., Steven E. Hyler, M.D.

    W52. Approaching Attention-Deficit Disorder in University Populations: Dosing, Diagnosing (and Detecting Those Just Looking for a Buzz)Chairs: Gordon D. Strauss, M.D., Beverly Fauman, M.D.

    W53. Psychiatry at a Crossroads: Our Changing Role in the House of MedicineAPA Council on Psychosomatic Medicine and Geriatric Psychiatry; Chair: Christopher W. Tjoa, M.D., B.S.

    W54. Motivational Therapy for Individuals With Concurrent DisordersChair: Shimi Kang, M.D.

    W55. Making the Most of Your Chief Year: Chief Residents' Forum IChair: Jonathan Amiel, M.D.(Open to residents only)

    W56. Patient Suicide During Psychiatry Residency: A Workshop DiscussionChairs: Meredith A. Kelly, M.D., Emily Gastelum, M.D.

    W57. Collateral Damage: Teaching Residents About the Impact of Patient SuicideChairs: Joan M. Anzia, M.D., Glen O. Gabbard, M.D.

    W58. Dynamic Therapy With Self-Destructive Borderlines: An Alliance-Based Intervention for SuicideChair: Eric M. Plakun, M.D.


    Courses 18-24



    SM8. Evidence-Based Psychodynamic TherapyChairs: Richard F. Summers, M.D., Jacques P. Barber, Ph.D.


    Courses 25-29


    Master Course

    MC04. Assessment and Treatment of Bipolar DisorderChairs: Terence A. Ketter, M.D., Po W. Wang, M.D.



    Case Conference

    CC2. Linking Medicine and Psychiatry: Clinical Cases in Psychosomatic MedicineChair: Michelle B. Riba, M.D., M.S.


    Focus Live 1

    Treatment-Resistant DisordersChair: Charles B. Nemeroff, M.D.,



    F3.DSM-5: Research and DevelopmentChairs: David J. Kupfer, M.D., Darrel A. Regier, M.D.



    L11. Wrongful Convictions: Challenges for Psychiatry and Forensic ScienceChair: Barry Scheck, J.D.

    L12. Distinguished Psychiatrist LectureNational Institute of Mental Health; Chair: David Lewis, M.D.

    L13. Judd Marmor Award LectureChair: Lawrence Siever, M.D.

    Small Interactive Sessions

    SI04. Opportunities in the Addiction Field: What You Should Know About Treatment, Training, and ResearchChair: Marc Galanter, M.D.(Open to residents only)

    SI05. Patients With Personality DisordersChair: John M. Oldham, M.D., M.S.(Open to residents only)



    W59. The War: Understanding and Confronting Scientology's Efforts to Destroy PsychiatryChair: Stephen R. Wiseman, M.D.

    W60. High-Yield Cognitive-Behavioral Therapy for Brief SessionsChair: Jesse H. Wright, M.D., Ph.D.



    Advances in Research

    AR1. Advances in ResearchChair: Herbert Pardes, M.D.

  • Anxiety Disorder in Children and Adolescents: State-of-the-Art Assessment and Treatment John Walkup, M.D.

  • Posttraumatic Stress Disorder, Major Depression, and the Risk for Suicidal Behavior Maria Oquendo, M.D.

  • Successful Cognitive Aging and Wisdom Dilip V. Jeste, M.D.

  • Depression and Diabetes: Unhealthy Bedfellows Wayne Katon, M.D.

  • +

    Media Workshop

    MW5. Psychotherapeutic Augmentation of Medication Checks Using Functional Analytic Psychotherapy (FAP)Chairs: Grant Miller, M.D., Barbara Kohlenberg, Ph.D.


    Presidential Symposium

    PS3. Psychiatry and Primary Care Collaboration Under Health Care Reform: Sustainable Models That Improve Access and QualityChair: Henry Chung, M.D.

  • Collaborative Care for College Students: The National College Depression Partnership (NCDP) Henry Chung, M.D.

  • Health Plan Implementation of Primary Care—€“Based Behavioral Health Services Hyong Un, M.D.

  • Improving Mental Health Care for Medical Outpatients: A Co-Location Model Using Psychiatrists in Urban Primary Care Settings Bruce Schwartz, M.D.

  • Improving Medical Care of Patients Receiving Behavioral Health Care Joseph Parks, M.D.

  • Achieving Comprehensive, Sustainable Models of Care in the Patient-Centered Medical Home Under Health Care Reform Frank Degruy, M.D.

  • +


    S34. Updates on Psychological Impacts of the Wars in Afghanistan and Iraq: Best Modalities of Screening and Treatment

  • Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center John Bradley, M.D.

  • Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center Scott Moran, M.D.

  • The Pacific Psychological Health Task Force: Enhancing Treatment Through Establishment of Partnerships in the Pacific Region Carroll Diebold, M.D.

  • Pharmacotherapy for PTSD in Combat Veterans: Challenges and Opportunities David Benedek, M.D.

  • Building DoD/VA/State and Community Partnership in Service to OEF/OIF Veterans and Their Families: Military Culture and Community Competence Harold Kudler, M.D.

  • S35. Teaching What Every Psychiatrist Needs to Know About Neuroscience

  • Teaching Neuroscience to Psychiatry Residents: What to Teach and How to Teach It Mayada Akil, M.D.

  • Integrating Neuroscience in the Training of Psychiatrists: The Yale Experience David Ross, M.D., Ph.D.

  • Organizing a Neuroscience Course Around the Research Domain Criteria Project (RDoC) Amit Etkin, M.D., Ph.D.

  • S36. The Shrinking Psychotherapeutic Pipeline: Why Has the Spigot Been Turned Off?

  • Increasing the Validity of Animal Models of Depression by Genetic-Environment Interactions Irwin Lucki, Ph.D.

  • New Drugs to No Drugs: Antidepressants and Drug Discovery/Development David Michelson, M.D.

  • Cross-Species Tests for Cognition Enhancement in Schizophrenia Mark Geyer, Ph.D.

  • Alzheimer's Disease Clinical Trial Failures: Ineffective Drugs or Flawed Clinical Trials? Nigel Greig, Ph.D.

  • S37. Is Whole Person Psychiatry Possible?

  • Whole Person Care in Psychiatry and in Palliative Medicine John Peteet, M.D.

  • Clinical Implications of Research on Healthy Personality Functioning C. Robert Cloninger, M.D.

  • Patient Preferences and Values: The Connecting Thread Between Evidence-Based Medicine and Cultural Competence Francis Lu, M.D.

  • Spirituality and Health: Guidelines for Clinical Care and Curriculum Development Christina Puchalski, M.D.

  • Comprehensive Treatment of Complex Patients: The Psychiatrist's Role Nadine Nyhus, M.D., M.A.

  • S38. Integrating Couples and Family Treatment Into Patient Care

  • How to Do a Biopsychosocial Formulation and Use Diagnostic Reasoning and Clinical Decision Making That Involve the Family Alison Heru, M.D.

  • Different Models of Family Intervention and Their Application to Psychiatric Disorders, Symptoms, and Situations Ira Glick, M.D.

  • S39. Harm Reduction and Prevention of Stalking

  • Stalking of Health Care Professionals: Reducing the Risk Gail E. Robinson, M.D.

  • Treatment of Stalkers Werner Tschan, M.D.

  • Stalking Behavior Among Juveniles: Opportunities for Early Intervention Rosemary Purcell, Ph.D.

  • Assessment and Management of Stalking and Threatening Activity in Campus Settings Mario Scalora, Ph.D.

  • S40. Evidence-Based Outcomes in Psychiatry: Updates on Measurement Using Patient-Reported Outcomes (PRO)APA Task Force on DSM-5

  • Patient-Reported Outcome Measures in DSM-5 William Narrow, M.D., M.P.H.

  • Patient Reported Outcomes Measurement Information System (PROMIS): Overview and Applications for Mental Health Research William Riley, Ph.D.

  • Patient-Reported Outcome Measure in Clinical Trials—€”An FDA Perspective June Cai, M.D.

  • International Pilot Study on Patient-Reported Outcomes in Schizophrenia Massimo Moscarelli, M.D.

  • S41. Longitudinal Course and Outcome in Borderline Personality Disorder

  • Parental Viewpoints on Trajectories to the Development of Borderline Personality Disorder in Males Marianne Goodman, M.D.

  • Rates of Recurrence of the Symptoms of BPD after Sustained Symptomatic Remission Mary Zanarini, Ed.D.

  • Prospective Predictors of Suicide Attempts in Borderline Personality Disorder at Six-Year Follow-Up Paul Soloff, M.D.

  • Prospective Risk Factors for Suicide Attempts in a Treated Sample of Patients With Borderline Personality Disorder (BPD) Paul Links, M.D.

  • S42. Madness and the City: Facing De- and Re-Institutionalization in Western European Metropolises

  • Characteristics and Impact of De- and Re-Institutionalization in Western Europe Joséphine Caubel, M.D.

  • Cities as Creators of Madness Wilco Tuinebreijer, M.D.

  • Integrative Care: The Way From Hospital to Outpatient Settings in Germany Jürgen Gallinat, Ph.D., M.D.

  • Birmingham: An Integrated Model of Hospital and Community Mental Health Service Provision Mervyn Morris, M.A., Ed.D.

  • Assertive Community Treatment in Amsterdam: The Dutch Answer to Deinstitutionalization Jeroen Zoeteman, M.D.

  • S43. Placebo Effects in Psychiatry

  • The Psychology and Psychodynamics of the Placebo Response Javier Garcia, M.D.

  • Placebo Effect in Clinical Trials Intikhab Ahmad, M.D.

  • Ethical Dilemmas in the Use of Placebo Joel Idowu, M.D.

  • The Neurobiology of Placebo Effects William Head, M.D.

  • The Placebo Effects in Clinical Practice Sheldon Blackman, Ph.D.

  • +


    Scientific and Clinical Reports

    SCR 20. Miscellaneous Topics/Diagnostic Issues

  • 67. Visualizing Mental Diseases: Distinct Plasma Levels of Cytokines and Chamokines in Schizophrenia and Major Depressive Disorder Sekiyama Atsuo, M.D., Ph.D.

  • 68. Conversion Disorder Presenting as Hemiplegia in a Patient With Familial Hemiplegic Migraine George Paris, M.D.

  • 69. Diagnostic Stability in Major Depressive Disorder With Versus Without Psychotic Features John Goethe, M.D.

  • +


    W61. Guardianship and Advance Directives in PsychiatryChair: Renée M. Sorrentino, M.D.

    W62. Behavioral Addictions: New Category in DSM-5Chairs: Ken Rosenberg, M.D., Charles O'Brien, M.D., Ph.D.

    W63. Gender-Specific Neurobiological, Behavioral, and Social Influence on Human Development: Implications for Heterosexual Relationships and Couples TherapyChair: Scott D. Haltzman, M.D.

    W64. Examining the Social Determinants of Mental Health Among Various Racial/Ethnic PopulationsChairs: Ruth S. Shim, M.D., M.P.H., Monica Taylor-Desir, M.D., M.P.H.

    W65. Making the Most of Your Chief Year: Chief Residents' Forum IIChair: Jonathan Amiel, M.D.(Open to residents only)

    W66. Professional Transitions: The PGY-4 Journey Through Terminations and Graduation to "Real Life"Chair: Joan M. Anzia, M.D.

    W67. NIMH Psychopharmacology Trials: How the Results Inform PracticeChair: Adelaide S. Robb, M.D.



    Advances in Medicine

    AM2. Update on Epilepsy: The Diagnosis and Management of Patients With "Spells"Chair: Alan G. Stein, M.D.


    Focus Live 2

    Substance AbuseChair: Marc Galanter, M.D.

    New Research Poster Session 6



    L14. Disease Biomarkers for Schizophrenia: From Laboratory to Patient BedsideChair: Sabine Bahn, M.D.

    L15. The Alienist in the 21st CenturyChair: Dinesh Bhugra, M.B.B.S., Ph.D.

    L16. 30 Years' Experiences in Providing Mental Health Care to Asian Refugees and ImmigrantsChair: Paul Leung, M.D.

    L17. Transforming Clinical Outcomes in AddictionChair: Nora D. Volkow, M.D.


    Small Interactive Sessions

    SI06. Child Psychopharmacology: Current ControversiesChair: Barbara J. Coffey, M.D., M.S.

    SI07. Top 10 Geriatric Psychiatry Issues for the General PsychiatristChair: Josepha A. Cheong, M.D.



    W68. Does the Brain Ever Recover From Drug Addiction?National Institute on Drug Abuse; Chair: Steven Grant, Ph.D.

    W69. Computer-Assisted Cognitive Behavioral Therapy (CCBT): Practical Implications for Everyday PracticeChairs: Jesse H. Wright, M.D., Amanda B. Mackey, M.D., Sarah B. Johnson, M.D., M.Sc.

    W70. Challenges in Treating andEvaluating PhysiciansChair: Glen O. Gabbard, M.D.


    Courses 30-35

    New Research Poster Session 6



    SM9. Overview of Recovery for PsychiatristsChair: Mark Ragins, M.D.

    SM10. Practical Guide to the Performance of the Mental Status ExaminationChair: Stephen I. Deutsch, M.D., Ph.D.



    Case Conference

    CC3. Evaluating and Treating the Psychological Effects of WarChairs: Elspeth C. Ritchie, M.D., Marvin Oleshansky, M.D.



    F5. Health Reform: Transforming Addiction Services in the United StatesNational Institute on Drug Abuse; Chairs: Wilson M. Compton, M.D., Nora D. Volkow, M.D.



    L19. Alexandra Symonds Award Lecture (moved to IPS meeting)

    L19. Stress, Cortisol, and Psychosis in DepressionChair: Alan F. Schatzberg, M.D.


    Media Workshop

    MW6. "Out in the Silence": A Film About Being Gay or Lesbian in Small-Town AmericaAmerican Academy of Child and Adolescent Psychiatry; Chair: Richard R. Pleak, M.D.


    Scientific and Clinical Reports

    SCR 21. Psychopharmacology 2

  • 70. Bruxism and Antidepressants Harvinder Singh, M.D.

  • 71. Rapid Response of Disabling Tardive Dyskinesia to a Short Course of Amantadine Gaurav Jain, M.D.

  • 72. Current Prescribing Practices: Antipsychotic Polypharmacy in Patients With Schizophrenia and Schizoaffective Disorder John Bonetti, D.O.

  • 73. Prescription Rates of Selective Serotonin Reuptake Inhibitors (SSRIs) After Introduction of Generic Equivalents: A Population-Based Study James Bolton, M.D.

  • SCR 22. Schizophrenia and Other Psychotic Disorders 2

  • 74. Parsing the Heterogeneity of Schizophrenia: The Utility of Four Early-Course Features in Subtyping First-Episode Nonaffective Psychosis Michael Compton, M.D., M.P.H.

  • 75. Mood Symptoms in Patients Presenting With Primary Psychosis After Age 40: A Prospective Cohort Study Rebecca Anglin, M.D.

  • 76. A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk Thomas Stroup, M.D., M.P.H.

  • 77. Meta-analysis of Phase 3 Trials of Iloperidone in the Short-Term Treatment of Schizophrenia: Efficacy Outcomes Based on Pretreatment Status Stephen Stahl, M.D., Ph.D.

  • +

    Small Interactive Sessions

    SI08. Successful Cognitive and Emotional Aging: How Can We Get There?Chair: Dilip V. Jeste, M.D.

    SI09. Management of Anxiety and Depression in the Medically IllChair: Catherine C. Crone, M.D.



    W71. Diagnostic Assessment in DSM-5: Approaches and ExamplesAmerican Psychiatric Institute for Research and Education; Chairs: David J. Kupfer, M.D., Darrel A. Regier, M.D.

    W72. Mental Health Issues and the Law of DeportationAPA Council on Psychiatry and Law; Chair: Patricia R. Recupero, J.D., M.D.

    W73. Primary Care Behavioral Health Integration: Roles of the Key Team MembersChair: Lori Raney, M.D.

    W74. The Older Adult Driver With Dementia: Safety Concerns and Physician InterventionsAPA Council on Adult Psychiatry; Chair: Helen H. Kyomen, M.D., M.S.

    W75. Models for Ma ximizing Clinical Revenues and Supporting the Academic Mission: A Joint Presentation of the AACDP and AAPChairs: Paul Summergrad, M.D., Radmila Bogdanich, M.A.

    W76. Going International: Improving International Medical Graduates' Training Experiences During Psychiatry ResidencyChair: Sanjeev Sockalingam, M.D.

    W77. What Have You Done for Me Lately: Identifying Early Career Psychiatrists' Needs and Resources Within the APA Membership CommitteeChair: Nioaka N. Campbell, M.D.



    Advances in Series

    A3. Advances in PsychotherapyChair: Glen O. Gabbard, M.D.

  • 1. Psychotherapies for Hyperarousal and Dissociative Subtypes of PTSD: Similarities and Differences David Spiegel, M.D.

  • 3. Psychotherapy With Suicidal Patients Barbara H. Stanley, Ph.D.

  • 4. Psychotherapy Plus: Medication for Addictive Disorders Charles O'Brien, M.D., Ph.D.

  • 5. Psychotherapy Induces Proliferation of Brain Serotonin 5-HT1A Receptors but Does Not Influence Dopamine D2/3 Receptors in Patients With Major Depressive Disorder Hasse Karlsson, M.D., Ph.D.

  • +

    Presidential Symposium 4

    PS4. Translating Neuroscience for Advancing Treatment and Prevention of Posttraumatic Stress DisorderChair: Charles Marmar, M.D.

  • Reconsolidation Blockade as a Novel Strategy for Treating PTSD Charles Marmar, M.D.

  • Targeting Peptides for Novel Pharmacological Treatments of PTSD Thomas Neylan, M.D.

  • Neuroscience Informed Strategies for Early Intervention for PTSD Arieh Y. Shalev, M.D.

  • Interrupting the Intergenerational Transmission of Trauma by Treating Maternal PTSD and Optimizing Maternal Care Claude M. Chemtob, Ph.D.

  • +


    S44. Comprehensive HIV Psychiatry Update

  • HIV/AIDS Medical Update The Very Right Rev. Drew A. Kovach, M.D., M.Div.

  • Neuropsychiatric Overview Marshall Forstein, M.D.

  • Neurocognitive Decline Karl Goodkin, M.D., Ph.D.

  • Psychopharmacology Stephen Ferrando, M.D.

  • S45. Research Update: New Developments in the Treatment of Mood DisordersNational Institute of Mental Health

  • New Insight Into the Neurobiology of Depression and the Development of Rapid-Acting Antidepressants and Biomarkers of Response Carlos Zarate, M.D.

  • Combining Medications to Enhance Depression Outcomes (CO-MED) Madhukar Trivedi, M.D.

  • TMS, Magnetic Seizure Therapy in Animals Holly Lisanby, M.D.

  • The NIMH Bipolar Trials Network Lithium Treatment Moderate Dose Use Study (LiTMUS): A Randomized, Comparative Effectiveness Trial of Adjunctive Lithium Joseph Calabrese, M.D.

  • S46. Recovery: Practical and Policy Lessons From Around the World

  • The Experience of Soul/Atman/Center/Hara/Seika Tanden/Spirit as an Essential Element of Being Necessary for Flourishing to Progress to Recovery Carl C. Bell, M.D.

  • The Impact of Health Reform on the Recovery Movement in America Steven Sharfstein, M.D., M.P.A.

  • Recovery: Practical and Policy Lessons From Around the World Jair Mari, M.D.

  • Recovery, Psychiatry, and Federal Mental Health Policy in the U.S. Kenneth Thompson, M.D.

  • S47. Treatment-Resistant Depression: A Roadmap for Effective Care

  • Treatment-Resistant Depression: Overview of the University of Michigan Depression Center Roadmap John F. Greden, M.D.

  • Psychopharmacological Roadmap for Treatment-Resistant Depression Srijan Sen, M.D.

  • Treatment-Resistant Depression Among Adolescents Neera Ghaziuddin, M.D.

  • Treatment-Resistant Depression: A Roadmap for Effective Care Michelle B. Riba, M.D.

  • Device-Related Neuromodulation in Treatment-Resistant Depression Daniel Maixner, M.D.

  • S48. Psychiatric Malpractice: Maintaining Solid Footing on Shaky Ground

  • Important Clinical and Legal Concepts Pertaining to Psychiatric Malpractice Craig Beach, M.D., M.Sc.

  • Cases to Illustrate Practical Strategies to Minimize Malpractice Risk and Navigate the Legal System in the Event of a Lawsuit Praveen Kambam, M.D.

  • What Really Occurs During a Malpractice Action Louis DelSignore, J.D.

  • Potential Emotional, Ethical, and Practical Implications of Being Sued Carolyn Wolf, J.D., M.S.

  • S49. Challenges and Conflicts in Professional Leadership at Psychiatric Institutions

  • Challenges and Conflicts in Professional Leadership at Psychiatric Institutions Robert Michels, M.D.

  • The Evolving Clinical-Administrative Function Richard Munich, M.D.

  • S50. Neural Correlates of Rapid Eye Movement (REM) and Dreaming: Implications for Dream Theory

  • Human Genotypic and Phenotypic Adaptations to Their Environments Jimmie Harris, D.O.

  • fMRI Evidence for Multisensory Recruitment Associated With Rapid Eye Movements During Sleep Charles Chong-Hwa Hong, M.D., Ph.D.

  • Imaging Correlates of Lucid Dreaming Renate Wehrle, Ph.D.

  • Quantitative EEG Correlates of Lucid Dreaming Ursula Voss, Ph.D.

  • S51. Bipolar Disorder: Controversies in Epidemiology and Treatment in Children and Adults in the U.S. and France: Vive la Difference!

  • More Childhood-Onset Bipolar Illness in the U.S. Than in Europe Robert Post, M.D.

  • Bipolar Disorder: Under- or Overdiagnosed Jean Michel Azorin, M.D.

  • Bipolar Disorder in Youth: Controversies in the U.S. and Abroad Robert Hendren, D.O.

  • Treatment Recommendations: The French Experience Philippe Courtet, M.D., Ph.D.

  • Prevalence and Characteristics of Bipolar Disorders in Patients With a Major Depressive Episode Charles Bowden, M.D.

  • The Challenge of Bipolar Depression Diagnosis and Treatment François Petitjean, M.D.

  • S52. Psychiatric and Behavioral Genetics: Ethical and Legal Challenges

  • Psychiatric and Behavioral Genetics and the Eugenic Legacy Paul S. Appelbaum, M.D.

  • Prenatal Genetic Screening for Psychiatric Disorders and Behavioral Traits Mildred Cho, Ph.D.

  • Newborn Genetic Screening: Legal and Ethical Concerns Steven Hoge, M.D., M.B.A.

  • Is Epigenetics a New Paradigm for Understanding Behavior? Nancy Press, Ph.D.

  • Ethical Issues in Psychopharmacogenetic Testing Jinger Hoop, M.D.

  • S53. What's the Difference That Makes the Difference? Commonalities and Differences Across Efficacious Treatments for BPD

  • Mentalization Based Treatment (MBT) and its Relationship to Other Psychotherapies for Borderline Personality Disorder Anthony Bateman, M.D.

  • Transference-Focused Psychotherapy: The Relationship in the Here-and-Now as the Key Frank Yeomans, M.D., Ph.D.

  • Dialectical Behavior Therapy Linda Dimeff, Ph.D.

  • TARA DBT-MBT Family Training Valerie Porr, M.A.

  • S54. Predictors, Moderators, and Mediators in Major Depressive Disorder

  • Predictors, Moderators, and Mediators of Symptom Improvement in Major Depressive Disorder: Focus on Clinical Factors George Papakostas, M.D.

  • Pharmacogenomics of Major Depression Julio Licinio, M.D.

  • Phosphorus-31 MRS Studies of High Energy Phosphates in MDD: Implications for Treatment Response and Novel Therapies Perry Renshaw, M.D., Ph.D.

  • Neurophysiologic Biomarkers for Predicting Treatment Outcome in MDD Andrew Leuchter, M.D.

  • S55. The Use of QEEG for Psychiatric Treatment Biomarkers

  • ATR-A QEEG-Based Biomarker of Treatment Response in Major Depression Dan Iosifescu, M.D., M.Sc.

  • Referenced-EEG (rEEG) Daniel Hoffman, M.D.

  • iSPOT Evian Gordon, Ph.D.

  • S56. Advances on Suicide Prevention: Preventing the Predictable

  • Personality and Life Events as Predictive Factors of Suicidal Behavior Hilario Blasco-Fontecilla, M.D., Ph.D.

  • Predictive Models in Suicidal Behavior Jorge Lopez-Castroman, M.D., Ph.D.

  • Novel Classification Tools for Suicide Prediction Fernando Perez-Cruz, B.Sc.

  • Data Mining, Suicide, and More: Our Experience M. Mercedes Perez-Rodriguez, M.D., Ph.D.

  • Implementation of All These Novel Tools in the Prevention of Suicide Jose de Leon, M.D.

  • S57. Collaborative Strategies Between Psychiatrists and Judges to Improve Outcomes for Defendants With Mental Illnesses

  • Overview of Topic Fred C. Osher, M.D.

  • The Judge's Role Steven Leifman, J.D.

  • Collaborative Strategies Between Psychiatrists and Judges to Improve Outcomes for Defendants With Mental Illnesses Annelle Primm, M.D., M.P.H.

  • How the Issue Impacts Hawaiians Marcia Waldorf, J.D.

  • +

    New Research Poster Session 7


    Convocation of Distinguished FellowsArchbishop Desmond Tutu, William C. Menninger Memorial Lecture29_1.inline-graphic-1.gif

    Interactive Graphics


    Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
    Related Articles